Treatment strategies after a single seizure : rationale for immediate versus deferred treatment

Laura C Miller1, Frank W Drislane

  • 1Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA.

CNS Drugs
|February 8, 2007
PubMed

Insights

Treating a first epileptic seizure is debated. Most neurologists wait for a second seizure to avoid unnecessary antiepileptic drug (AED) complications, as delaying treatment doesn't worsen epilepsy outcomes.

Area of Science:

  • Neurology
  • Clinical Medicine

Background:

  • The decision to treat a first epileptic seizure is complex, with varying risks of recurrence.
  • Existing studies on seizure recurrence often involve children or patients already on antiepileptic drugs (AEDs), potentially underestimating untreated recurrence risks.

Purpose of the Study:

  • To examine the rationale for treating a first epileptic seizure versus deferring treatment until a second seizure occurs.
  • To review the evidence regarding the impact of delayed treatment on epilepsy course and seizure control.

Main Methods:

  • Review of existing studies on seizure recurrence risk after a first unprovoked seizure.
  • Analysis of factors influencing seizure recurrence, including underlying causes and patient-specific conditions.

Main Results:

  • The risk of a second unprovoked seizure is less than 50%, though study methodologies vary.
  • Delaying antiepileptic drug (AED) treatment until a second seizure does not appear to worsen the long-term course of epilepsy or seizure control.
  • Acute symptomatic seizures typically resolve with treatment of the underlying illness, often not requiring long-term AEDs.

Conclusions:

  • Waiting for a second seizure is a common recommendation to prevent unnecessary antiepileptic drug (AED) exposure and side effects.
  • Certain conditions like stroke, tumors, infections, dementia, head injury, or neurosurgery warrant special consideration for earlier treatment.
  • Individual patient preferences regarding risk and benefit are crucial in the decision to initiate AED treatment after a single seizure.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...